Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?

Recently, an increasing number of novel drugs were approved in oncology and hematology. Nevertheless, pharmacology progress comes with a variety of side effects, of which cytokine release syndrome (CRS) is a potential complication of some immunotherapies that can lead to multiorgan failure if not di...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Constantinescu, Catalin, Pasca, Sergiu, Tat, Tiberiu, Teodorescu, Patric, Vlad, Catalin, Iluta, Sabina, Dima, Delia, Tomescu, Dana, Scarlatescu, Ecaterina, Tanase, Alina, Sigurjonsson, Olafur Eysteinn, Colita, Anca, Einsele, Hermann, Tomuleasa, Ciprian
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Hypothesis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7264828/
https://ncbi.nlm.nih.gov/pubmed/32474415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000742
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars